INO Therapeutics LLC, a foreign-owned for-profit company, has been awarded multiple federal contracts and Blanket Purchase Agreements (BPAs) by the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency to provide inhaled nitric oxide therapy systems, medical gases, and related services. The company has been the prime contractor on over 50 such federal contracts since 2002, supplying nitric oxide cylinders, gases, delivery machines, labor, and equipment to support respiratory treatments and related healthcare programs for veterans, service members, and military beneficiaries.
The contracts, awarded under the Pharmaceuticals and Drugs GSA Federal Supply Schedule 61-IB without any set-aside designations, have a total potential value exceeding $36 million. They include delivery orders for the provision of nitric oxide gas, INOmax therapy, and INOtherapy services to VA medical centers and clinics across multiple Veterans Integrated Service Networks, as well as to military treatment facilities on behalf of the Defense Health Agency. Additionally, INO Therapeutics holds two active IDIQ BPAs with the VA to facilitate future orders for INOmax cylinder delivery services and INO-therapy through 2024 and 2022, respectively.
Generated 11/17/24, 12:00 AM